<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
<channel>
                    <title>Medical Xpress news tagged with:chronic hepatitis c</title>
            <link>https://medicalxpress.com/</link>
            <language>en-us</language> 
            <description>Medical Xpress internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

                            <item>
                    <title>Point-of-care hepatitis B DNA testing proves as accurate as lab tests</title>
                    <description>A clinical trial led by Kirby Institute at UNSW Sydney has found that point-of-care testing for hepatitis B DNA is as effective as traditional laboratory testing, paving the way for faster diagnosis and treatment in hard-to-reach communities. The results have been published in the Journal of Clinical Microbiology.</description>
                    <link>https://medicalxpress.com/news/2026-02-hepatitis-dna-accurate-lab.html</link>
                    <category></category>
                    <pubDate>Sun, 08 Feb 2026 15:00:02 EST</pubDate>
                    <guid isPermaLink="false">news689512315</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/finger-blood.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Chronic hepatitis C linked to increased risk of pancreatic cancer</title>
                    <description>A new study from Yale School of Medicine researchers has found a positive link between chronic hepatitis C and pancreatic cancer. The study, which was published in JAMA Network Open, revealed that individuals with chronic hepatitis C virus (HCV) infection have a 1.8-fold increased risk of pancreatic cancer compared to those who test negative for the virus. In comparison, well-known risk factors, like diabetes or active smoking, increased the likelihood of pancreatic cancer by 1.2- or 1.3-fold.</description>
                    <link>https://medicalxpress.com/news/2025-11-chronic-hepatitis-linked-pancreatic-cancer.html</link>
                    <category></category>
                    <pubDate>Thu, 20 Nov 2025 14:30:02 EST</pubDate>
                    <guid isPermaLink="false">news682867590</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/chronic-hepatitis-c-li.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Depression linked to presence of immune cells in the brain&#039;s protective layer</title>
                    <description>Immune cells released from bone marrow in the skull in response to chronic stress and adversity could play a key role in symptoms of depression and anxiety, say researchers.</description>
                    <link>https://medicalxpress.com/news/2025-09-depression-linked-presence-immune-cells.html</link>
                    <category></category>
                    <pubDate>Mon, 01 Sep 2025 10:37:05 EDT</pubDate>
                    <guid isPermaLink="false">news675941822</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/depression-linked-to-p-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Study identifies trends from 2015–2023 mortality for chronic liver disease</title>
                    <description>Distinct trends were seen in etiology-based mortality with chronic liver disease (CLD) before, during, and after the COVID-19 pandemic, according to a research letter published online April 29 in the Annals of Internal Medicine.</description>
                    <link>https://medicalxpress.com/news/2025-05-trends-mortality-chronic-liver-disease.html</link>
                    <category></category>
                    <pubDate>Thu, 08 May 2025 15:59:03 EDT</pubDate>
                    <guid isPermaLink="false">news665938741</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/study-ids-trends-in-20.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Prison needle programs could save millions in hepatitis C treatment costs</title>
                    <description>A new Australian-first study from the Burnet Institute has found that every dollar invested in Australian prison needle and syringe programs could save more than two dollars in treatment costs for hepatitis C and injection-related infections.</description>
                    <link>https://medicalxpress.com/news/2025-04-prison-needle-millions-hepatitis-treatment.html</link>
                    <category></category>
                    <pubDate>Mon, 21 Apr 2025 07:55:04 EDT</pubDate>
                    <guid isPermaLink="false">news664440901</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/syringes.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Hepatitis C in Australia has more than halved in less than a decade, says report</title>
                    <description>In 2023, there were an estimated 68,890 people living with hepatitis C in Australia, down 58% from 162,590 at the end of 2015, according to a new report released by the Kirby Institute at UNSW Sydney.</description>
                    <link>https://medicalxpress.com/news/2024-12-hepatitis-australia-halved-decade.html</link>
                    <category></category>
                    <pubDate>Mon, 16 Dec 2024 12:38:35 EST</pubDate>
                    <guid isPermaLink="false">news653575109</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2023/people.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Revealing disparities in hepatitis C care for reproductive-aged women to break cycle of viral transmission</title>
                    <description>Most pediatric cases of hepatitis C virus (HCV) infection are perinatal, meaning the virus is transmitted from birthing parent to child during pregnancy or birth, according to the Centers for Disease Control and Prevention. If left untreated, hepatitis C infection can lead to worse outcomes later in life, such as chronic liver disease, liver failure, and liver cancer. Identifying disparities in testing and treating hepatitis C among people of reproductive age with opioid use disorder can improve health outcomes for all birthing parents and children.</description>
                    <link>https://medicalxpress.com/news/2024-10-revealing-disparities-hepatitis-reproductive-aged.html</link>
                    <category></category>
                    <pubDate>Mon, 07 Oct 2024 16:10:01 EDT</pubDate>
                    <guid isPermaLink="false">news647535556</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2019/2-pregnant.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Cross-disciplinary research makes strides in hepatitis C vaccine development</title>
                    <description>Around 58 million people suffer from chronic inflammation caused by the hepatitis C virus, and 300,000 people die from the disease every year.</description>
                    <link>https://medicalxpress.com/news/2024-09-disciplinary-hepatitis-vaccine.html</link>
                    <category></category>
                    <pubDate>Mon, 09 Sep 2024 10:58:04 EDT</pubDate>
                    <guid isPermaLink="false">news645098282</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2024/were-closer-than-ever.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Treatment with direct-acting antivirals found to improve HCV-related disease outcomes</title>
                    <description>Hepatitis C virus (HCV)-related diseases such as chronic hepatitis C, liver cirrhosis, and liver cancers afflict a large number of people worldwide. A recent study from Korea University suggests that treatment with direct-acting antivirals (DAAs) improves liver disease-related clinical outcomes in patients with chronic HCV infection and reduces liver fibrosis-based disease burden. It further highlights that timely intervention with advanced antiviral therapies can have a positive impact on public health.</description>
                    <link>https://medicalxpress.com/news/2024-08-treatment-antivirals-hcv-disease-outcomes.html</link>
                    <category></category>
                    <pubDate>Tue, 20 Aug 2024 16:58:04 EDT</pubDate>
                    <guid isPermaLink="false">news643391882</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2024/korea-university-offer.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Hepatitis C leaves &#039;scars&#039; in immune cells even after successful treatment</title>
                    <description>Chronic hepatitis C, caused by the hepatitis C virus, can lead to severe complications such as liver cirrhosis and liver cancer. The advent of highly effective direct-acting antivirals (DAAs) has resulted in high cure rates for this chronic viral infection. However, it has been reported that the immune system of patients does not fully recover even after being cured.</description>
                    <link>https://medicalxpress.com/news/2024-07-hepatitis-scars-immune-cells-successful.html</link>
                    <category></category>
                    <pubDate>Tue, 09 Jul 2024 09:17:03 EDT</pubDate>
                    <guid isPermaLink="false">news639735421</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2024/hepatitis-c-leaves-sca.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>In people with opioid use disorder, telemedicine for HCV was more than twice as successful as off-site referral</title>
                    <description>People with opioid use disorder who have hepatitis C virus (HCV) were twice as likely to be successfully treated and cured from HCV if they received facilitated telemedicine treatment at their opioid treatment program (OTPs) than if they were referred off-site to another provider. Those are the findings published today by a University at Buffalo team of researchers in the Journal of the American Medical Association (JAMA).</description>
                    <link>https://medicalxpress.com/news/2024-04-people-opioid-disorder-telemedicine-hcv.html</link>
                    <category></category>
                    <pubDate>Wed, 03 Apr 2024 11:00:01 EDT</pubDate>
                    <guid isPermaLink="false">news631353826</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2024/jama-paper-in-people-w.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Hepatitis C virus infection: Research team discovers that a protein has an unexpected proviral effect</title>
                    <description>A research team from the Paul-Ehrlich-Institut has gained important insights into the role of the human guanylate-binding protein 1 (GBP1) in hepatitis C virus infection. Their results show that GBP1 performs a previously unknown function, that of a proviral factor, during the HCV life cycle.</description>
                    <link>https://medicalxpress.com/news/2024-03-hepatitis-virus-infection-team-protein.html</link>
                    <category></category>
                    <pubDate>Tue, 26 Mar 2024 12:20:38 EDT</pubDate>
                    <guid isPermaLink="false">news630674432</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2024/hepatitis-c-virus-infe.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Guidance for prevention, diagnosis, evaluation, treatment of hepatitis C virus in chronic kidney disease</title>
                    <description>The latest clinical practice guideline from the Kidney Disease: Improving Global Outcomes (KDIGO) organization offers guidance for the prevention, diagnosis, evaluation, and treatment of hepatitis C virus (HCV) in chronic kidney disease (CKD).</description>
                    <link>https://medicalxpress.com/news/2023-12-guidance-diagnosis-treatment-hepatitis-virus.html</link>
                    <category></category>
                    <pubDate>Mon, 11 Dec 2023 17:00:02 EST</pubDate>
                    <guid isPermaLink="false">news621530597</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2020/2-kidney.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Researchers: We&#039;re on track to eliminate hepatitis C, but stigma remains and reinfection is a risk</title>
                    <description>Hepatitis C is a preventable but potentially life-threatening blood-borne virus. It primarily affects the liver and, if untreated, can lead to cirrhosis (scar damage) and cancer.</description>
                    <link>https://medicalxpress.com/news/2023-12-track-hepatitis-stigma-reinfection.html</link>
                    <category></category>
                    <pubDate>Mon, 11 Dec 2023 12:58:19 EST</pubDate>
                    <guid isPermaLink="false">news621521895</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2014/hepatitisc.png" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Addressing the need to treat hepatitis C in pregnancy and infancy</title>
                    <description>Driven by the ongoing opioid epidemic and the sharing of needles, hepatitis C cases have been rising in the United States over the last decade, with the highest infection rates among young adults, including women of childbearing age. Without treatment, hepatitis C can lead to acute and chronic hepatitis, increasing the risk of liver cancer, liver failure and other conditions.</description>
                    <link>https://medicalxpress.com/news/2023-11-hepatitis-pregnancy-infancy.html</link>
                    <category></category>
                    <pubDate>Wed, 08 Nov 2023 11:10:01 EST</pubDate>
                    <guid isPermaLink="false">news618663743</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2023/mother-and-infant-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Increase in hepatitis A vaccination needed to prevent deaths</title>
                    <description>Nearly two-thirds of those with hepatitis A virus (HAV)-related deaths have at least one documented indication for HAV vaccine, and only 4% have evidence of vaccination, according to research published in the Oct. 20 issue of Morbidity and Mortality Weekly Report.</description>
                    <link>https://medicalxpress.com/news/2023-10-hepatitis-vaccination-deaths.html</link>
                    <category></category>
                    <pubDate>Thu, 26 Oct 2023 09:30:01 EDT</pubDate>
                    <guid isPermaLink="false">news617528145</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2023/increase-in-hepatitis.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Hepatitis C: Britons getting tattoos and cosmetic procedures abroad may be at risk—here&#039;s how to avoid it</title>
                    <description>A growing number of people living in the UK are going abroad to have tattoos, piercings and cosmetic surgeries. Any procedure, no matter where it&#039;s performed, can carry the risk of injury and infection.</description>
                    <link>https://medicalxpress.com/news/2023-09-hepatitis-britons-tattoos-cosmetic-procedures.html</link>
                    <category></category>
                    <pubDate>Fri, 29 Sep 2023 12:13:04 EDT</pubDate>
                    <guid isPermaLink="false">news615208381</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2023/hepatitis-c-britons-ge.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Clinic is detecting—and treating—hepatitis C virus in infants</title>
                    <description>A pediatric infectious disease team led by University at Buffalo faculty is screening and treating hepatitis C virus (HCV)-exposed infants. The clinic&#039;s efforts are documented in a new paper based on an 11-year retrospective chart review, published this month in BMC Gastroenterology.</description>
                    <link>https://medicalxpress.com/news/2023-07-clinic-detectingand-treatinghepatitis-virus-infants.html</link>
                    <category></category>
                    <pubDate>Thu, 27 Jul 2023 11:11:32 EDT</pubDate>
                    <guid isPermaLink="false">news609675087</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2019/4-infant.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Researchers solve the mystery of how a deadly virus hides in humans</title>
                    <description>With a new method for examining virus samples researchers from the University of Copenhagen have solved an old riddle about how Hepatitis C virus avoids the human body&#039;s immune defenses. The result may have an impact on how we track and treat viral diseases in general.</description>
                    <link>https://medicalxpress.com/news/2023-07-mystery-deadly-virus-humans.html</link>
                    <category></category>
                    <pubDate>Wed, 05 Jul 2023 11:33:03 EDT</pubDate>
                    <guid isPermaLink="false">news607775581</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2020/2-virus.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>How do you get hepatitis C? Here&#039;s what to know</title>
                    <description>Hepatitis C is a viral infection of the liver no one wants to catch, so knowing how that can happen can be critical.</description>
                    <link>https://medicalxpress.com/news/2023-06-hepatitis.html</link>
                    <category></category>
                    <pubDate>Thu, 15 Jun 2023 13:49:27 EDT</pubDate>
                    <guid isPermaLink="false">news606055762</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2023/how-do-you-get-hepatit.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>There is no vaccine for hepatitis C: Getting tested could save your life</title>
                    <description>The hepatitis vaccines you receive as a child don&#039;t protect you from getting hepatitis C, a serious disease that can have fatal consequences including liver damage, cirrhosis and liver cancer.</description>
                    <link>https://medicalxpress.com/news/2022-11-vaccine-hepatitis-life.html</link>
                    <category></category>
                    <pubDate>Tue, 22 Nov 2022 10:33:03 EST</pubDate>
                    <guid isPermaLink="false">news588335582</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2022/hepatitis-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Study provides basis for personalized hepatitis C aftercare</title>
                    <description>Even after chronic hepatitis C has been cured, portal hypertension remains the major factor driving the development of complications in advanced liver disease. In cooperation with researchers from Spain, a research team led by Georg Semmler and Mattias Mandorfer from the Division of Gastroenterology and Hepatology at MedUni Vienna&#039;s Department of Medicine III showed that the non-invasive tests explored in their earlier studies accurately estimate the probability of sequelae.</description>
                    <link>https://medicalxpress.com/news/2022-11-basis-personalized-hepatitis-aftercare.html</link>
                    <category></category>
                    <pubDate>Thu, 03 Nov 2022 11:37:02 EDT</pubDate>
                    <guid isPermaLink="false">news586694221</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2022/study-provides-basis-f.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Hepatitis C patients cured with antiviral medicines are less likely to be hospitalized, need ER care for liver</title>
                    <description>Researchers at Henry Ford Health System, as part of a national hepatitis C collaborative, report that patients with chronic hepatitis C who are treated with direct-acting antiviral medicines are less likely to be hospitalized or seek emergency care for liver and non-liver related health issues.</description>
                    <link>https://medicalxpress.com/news/2022-02-hepatitis-patients-antiviral-medicines-hospitalized.html</link>
                    <category></category>
                    <pubDate>Fri, 18 Feb 2022 17:06:26 EST</pubDate>
                    <guid isPermaLink="false">news564426379</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2014/hepatitisc.png" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Chronic hepatitis C is expensive for Ontario patients and caregivers</title>
                    <description>Ontarians with chronic hepatitis C can lose up to 20 percent of their overall income managing their condition, a new study has found.</description>
                    <link>https://medicalxpress.com/news/2021-11-chronic-hepatitis-expensive-ontario-patients.html</link>
                    <category></category>
                    <pubDate>Mon, 01 Nov 2021 03:38:04 EDT</pubDate>
                    <guid isPermaLink="false">news554956680</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2014/hepatitisc.png" width="90" height="90" />
                                    </item>
                            <item>
                    <title>How hepatitis C virus evades the immune system</title>
                    <description>Hepatitis C virus (HCV) may cause chronic infection to the liver, which can result in irreversible liver damage and liver cancer. How HCV manages to evade the immune system to infect the host chronically is not entirely understood. In a new study, researchers from Osaka University discovered a novel molecular mechanism by which HCV interferes with the host&#039;s immune system to cause chronic liver infection. These findings may help establish a novel therapy against chronic HCV infection.</description>
                    <link>https://medicalxpress.com/news/2021-05-hepatitis-virus-evades-immune.html</link>
                    <category></category>
                    <pubDate>Mon, 24 May 2021 15:00:03 EDT</pubDate>
                    <guid isPermaLink="false">news541068301</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2021/how-hepatitis-c-virus.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Long-term suppression of hepatitis B in patients with HIV may lower cancer risk</title>
                    <description>While the risk of hepatocellular carcinoma (HCC) – primary liver cancer—is higher among patients who have HIV, it&#039;s even higher among patients who have HIV and detectable hepatitis B, according to research from the Perelman School of Medicine at the University of Pennsylvania. Among participants with HIV and hepatitis B, suppressing detectable hepatitis B infection with the use of antiretroviral therapy cut the risk of developing HCC by 58 percent. These findings suggest that the best care for individuals with HIV and detectable hepatitis B includes sustained hepatitis B suppression with antiretroviral therapy in order to cut the risk of developing HCC. The study is published in the journal Hepatology.</description>
                    <link>https://medicalxpress.com/news/2021-05-long-term-suppression-hepatitis-patients-hiv.html</link>
                    <category></category>
                    <pubDate>Fri, 21 May 2021 09:51:44 EDT</pubDate>
                    <guid isPermaLink="false">news540809501</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2014/hepatitisb.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Hepatitis B: What people can learn from donkeys</title>
                    <description>The discovery of a previously unknown hepatitis B virus in donkeys and zebras opens up new opportunities for understanding the course of the disease. A global research consortium was able to show that the course of the infection with this virus is similar to that of chronic hepatitis B in humans. The study was led by DZIF scientists at the Charité - Universitätsmedizin Berlin and the Justus Liebig University Giessen.</description>
                    <link>https://medicalxpress.com/news/2021-03-hepatitis-people-donkeys.html</link>
                    <category></category>
                    <pubDate>Wed, 17 Mar 2021 11:30:56 EDT</pubDate>
                    <guid isPermaLink="false">news535199445</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2021/hepatitisbwh.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>A researcher reflects on progress fighting hepatitis C, and a path forward</title>
                    <description>When I began my medical career in Hong Kong in the early 1980s, I chose to focus on hepatitis B, in part because it was very common and because the hepatitis C virus had not yet been discovered. I witnessed the devastation that this virus caused—cirrhosis, liver failure and liver cancer—and the lack of treatments we could offer to patients.</description>
                    <link>https://medicalxpress.com/news/2020-10-hepatitis-path.html</link>
                    <category></category>
                    <pubDate>Tue, 06 Oct 2020 09:20:02 EDT</pubDate>
                    <guid isPermaLink="false">news521193735</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2014/hepatitisc.png" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Prophylactic antivirals prevent chronic hepatitis C in patients receiving kidneys from positive donors</title>
                    <description>Prophylactic treatment with direct-acting antivirals (DAAs) prevented chronic hepatitis C virus (HCV) infection in 10 patients receiving kidneys from HCV positive deceased donors. This approach has potential to help shorten waiting times on the organ waitlist. A brief research report is published in Annals of Internal Medicine.</description>
                    <link>https://medicalxpress.com/news/2020-09-prophylactic-antivirals-chronic-hepatitis-patients.html</link>
                    <category></category>
                    <pubDate>Tue, 08 Sep 2020 04:05:19 EDT</pubDate>
                    <guid isPermaLink="false">news518756701</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2014/hepatitisc.png" width="90" height="90" />
                                    </item>
                            <item>
                    <title>New models help predict liver cancer after successful hepatitis C virus treatment</title>
                    <description>Predicting who may go on to develop hepatocellular carcinoma (HCC) after successful treatment for chronic hepatitis C virus (HCV) infection may now be easier, thanks to the work of two independent research teams from France and Egypt. The studies, presented at the Digital International Liver Congress (DILC) 2020, included cohorts of patients with chronic HCV infection who achieved a sustained virological response (SVR) to direct-acting antiviral (DAA) therapy. The studies used readily available clinical parameters to find those at lowest and highest risk of developing HCC in the future. This, the researchers say, could help to individualize HCC surveillance and detect HCC after HCV is cured as early as possible.</description>
                    <link>https://medicalxpress.com/news/2020-08-liver-cancer-successful-hepatitis-virus.html</link>
                    <category></category>
                    <pubDate>Thu, 27 Aug 2020 09:16:48 EDT</pubDate>
                    <guid isPermaLink="false">news517738607</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2014/hepatitisc.png" width="90" height="90" />
                                    </item>
                    </channel>
</rss>
